Patents by Inventor Haim Meshulam

Haim Meshulam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020160988
    Abstract: Chimeric compounds are disclosed which are covalent conjugates of reversible or irreversible cholinergic up-regulators and non-steroidal anti-inflammatory drugs (NSAIDs), methods for their synthesis and use thereof for treatment and/or prevention of central nervous system (CNS) disorders and diseases.
    Type: Application
    Filed: July 16, 2001
    Publication date: October 31, 2002
    Applicant: Israel Institute for Biological Research
    Inventors: Gabriel Amitai, Rachel Adani, Ishai Rabinovitz, Gali Sod-Moriah, Haim Meshulam
  • Patent number: 5852029
    Abstract: Compounds useful for treating diseases of the central or peripheral nervous system in mammals have formulae I-XII ##STR1## wherein ring A or A' together with the spiro-carbon atom constitutes a bridged or unbridged ring containing one or two ring nitrogen atoms; and the other symbols have specified values, subject to certain conditions.
    Type: Grant
    Filed: January 18, 1996
    Date of Patent: December 22, 1998
    Assignee: Israel Institute for Biological Research
    Inventors: Abraham Fisher, Yishal Karton, Daniele Marciano, Dov Barak, Haim Meshulam
  • Patent number: 5534520
    Abstract: Compounds useful for treating diseases of the central or peripheral nervous system in mammals have formulae I-XIII: ##STR1## wherein ring A or A' together with the spiro-carbon atom constitutes a bridged or unbridged ring containing one or two ring nitrogen atoms; and the other symbols have specified values, subject to certain conditions.
    Type: Grant
    Filed: July 20, 1993
    Date of Patent: July 9, 1996
    Inventors: Abraham Fisher, Yishai Karton, Daniele Marciano, Dov Barak, Haim Meshulam
  • Patent number: 5407938
    Abstract: The invention relates to compounds (I) for treating diseases of the central and peripheral nervous system, including enantiomers, racemates and acid addition and quaternary salts, ##STR1## wherein Q is selected from two H atoms, (CH.sub.2).sub.m and C(CH.sub.3).sub.2 where m is 1, 2 or 3 and n and p are; each independently 0, 1, 2 or 3, provided that n+p=1-3, and R.sup.0 is H, methyl or OH; the moiety ##STR2## R is selected from H, NH.sub.2, NH-C.sub.1-6 -alkyl, N(C.sub.1-6 -alkyl).sub.2, C.sub.1-6 -alkyl, C.sub.2-6 -alkenyl, C.sub.2-6 -alkynyl, C.sub.3-7 - cycloalkyl, C.sub.1-6 -alkyl substituted by 1-6 halogen atoms, hydroxy- C.sub.1-6 -alkyl, C.sub.1-6 -alkoxy, C.sub.1-6 -alkylthio, C.sub.1-6 -alkoxy-C.sub.1-6 -alkyl, carboxy-C.sub.1-6 -alkyl, (C.sub.1-6 -alkoxy)carbonyl-C.sub.1-6 -alkyl, amino-C.sub.1-6 -alkyl, mono-(C.sub.1-6 -alkyl)amino-C.sub.1-6 -alkyl, di-(C.sub.1-6 -alkyl)amino-C.sub.1-6 -alkyl, 2-oxo-pyrrolidin-1-yl-methyl, aryl, diarylmethylol, and C.sub.
    Type: Grant
    Filed: October 14, 1993
    Date of Patent: April 18, 1995
    Assignee: Israel Institute for Biological Research
    Inventors: Abraham Fisher, Yoffi Segall, Ezra Shirin, Yishai Karton, Haim Meshulam